MRG-002 (MedRegen)

N/A

Report date: 2025/12/23 14:20:26
NME

Base Information

Drug NameMRG-002 (MedRegen)
Drug Alias Nameplerixafor/FKVPMRG-002MRG002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone morphogenetic proteins modulatorsC-X-C motif chemokine receptor 4 antagonists
TargetsBone morphogenetic proteinsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsBurnsWounds and InjuriesDiabetic Foot +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Plerixafor
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedRegen LLC
China Registration ClassN/A

Develop Information

Active CompaniesMedRegen LLC
Inactive CompaniesN/A
Active IndicationsBurnsDiabetic FootLiver Diseases
Inactive IndicationsWounds and Injuries

Other Information

ATC CodeN/A
Related LinksN/A